Product Code: ETC11393377 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Antihypertensives Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Antihypertensives Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Antihypertensives Market - Industry Life Cycle |
3.4 Philippines Antihypertensives Market - Porter's Five Forces |
3.5 Philippines Antihypertensives Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Antihypertensives Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Philippines Antihypertensives Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Antihypertensives Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension in the Philippines |
4.2.2 Growing awareness about the importance of hypertension management and treatment |
4.2.3 Rising healthcare expenditure and improving access to healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antihypertensive drugs |
4.3.2 High competition among existing antihypertensive drug manufacturers |
4.3.3 Limited healthcare infrastructure and resources in certain regions of the Philippines |
5 Philippines Antihypertensives Market Trends |
6 Philippines Antihypertensives Market, By Types |
6.1 Philippines Antihypertensives Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Antihypertensives Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Philippines Antihypertensives Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.1.4 Philippines Antihypertensives Market Revenues & Volume, By Monotherapy, 2021 - 2031F |
6.2 Philippines Antihypertensives Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Philippines Antihypertensives Market Revenues & Volume, By ARBs, 2021 - 2031F |
6.2.3 Philippines Antihypertensives Market Revenues & Volume, By CCBs, 2021 - 2031F |
6.2.4 Philippines Antihypertensives Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.3 Philippines Antihypertensives Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Antihypertensives Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Philippines Antihypertensives Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 Philippines Antihypertensives Market Revenues & Volume, By Hospital, 2021 - 2031F |
7 Philippines Antihypertensives Market Import-Export Trade Statistics |
7.1 Philippines Antihypertensives Market Export to Major Countries |
7.2 Philippines Antihypertensives Market Imports from Major Countries |
8 Philippines Antihypertensives Market Key Performance Indicators |
8.1 Patient adherence rate to antihypertensive treatment |
8.2 Number of healthcare facilities offering hypertension screening and management services |
8.3 Percentage of hypertensive patients achieving blood pressure control through medication and lifestyle modifications. |
9 Philippines Antihypertensives Market - Opportunity Assessment |
9.1 Philippines Antihypertensives Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Antihypertensives Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Philippines Antihypertensives Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Antihypertensives Market - Competitive Landscape |
10.1 Philippines Antihypertensives Market Revenue Share, By Companies, 2024 |
10.2 Philippines Antihypertensives Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |